Nelson Biotech Start-up Kimer Med Signs Contract With Battelle Memorial Institute To Advance Pioneering Antiviral Drugs

Friday, 8 March 2024, 9:02 pm | Kimer Med

12 month contract focused on the development of new antiviral drugs Novel candidates to be produced using Kimer Med's broad-spectrum antiviral platform There are currently no approved antivirals for 95% of viral diseases Kimer Med, a Nelson biotech start-up, ... More >>